# Citius Oncology, Inc.: Form 10-Q for the period ended Jun 30, 2023

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: 10-Q
- Filed: 2023-08-16
- Accepted by EDGAR: Aug 16, 2023, 14:44 ET
- Period: 2023-06-30
- Accession: 0001493152-23-029131
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000149315223029131/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000149315223029131/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 3 months, 2023-04-01 to 2023-06-30 | −$199.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2023-01-01 to 2023-06-30 | −$347.5k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2023-04-01 to 2023-06-30 | $616.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2023-01-01 to 2023-06-30 | $1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-04-01 to 2023-06-30 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2023-01-01 to 2023-06-30 | $0.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-04-01 to 2023-06-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2023-01-01 to 2023-06-30 | $0.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-04-01 to 2023-06-30 | 6,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2023-01-01 to 2023-06-30 | 6,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2023-01-01 to 2023-06-30 | −$269.1k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2023-06-30 | $370.1k | us-gaap:Cash |
| Current assets | at 2023-06-30 | $461.9k | us-gaap:AssetsCurrent |
| Total assets | at 2023-06-30 | $69.9m | us-gaap:Assets |
| Current liabilities | at 2023-06-30 | $463.9k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2023-06-30 | −$2.0k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000149315223029131/form10-q.htm

Filed Aug 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-029131. Last ingested by Listed: Nov 14, 2026, 21:33 ET. No prices; not investment advice.
